Pathogens Name, Morphology of Virus Genome Culturing Antigenic Routes and modes of Microbiologic Diagnosis : Preparations for Treatment
icrobiologic Diagnosis : Preparations for Treatment and
taxonomy Properties transmission Specimens and Methods of Examination Immunoprophylaxis ARVI Acute respiratory viral Tissue culture Person to person Diagnosis by culture, antigenic detection or serology Treatment infection Chicken Respiratory droplets embryo A. Specimen No ARVI-specific antiviral therapy except for Common cold Lab. Animals Nasophranygeal aspirates influenza They are Intranasal and topical interferon- is Dna containing virus Non-enveloped Double 41 known B. Rapid Diagnosis effective obligate Icosahedral stranded DNA intracellular antigenic Detect viral antigens F: Adenoviridae nucleocapsid types By immunofluorescence method using fluorescence Immunoprophylaxis G: Mastanedovirus 3,4,7 labeled specific antibodies Also by enzymatic immunoassay Only for adenoviral and influenza Immunity against one serotype not cross RNA- containing virus RNA envelope Segmented (8 H-an C. Virological protective viruses pieces) N-an Inoculation onto tissue culture Maybe transient F: Orthomyxoviridae Helical capsule Identification of virus is performed by examination of To prevent reinfecion- specific serum and G: Influenza virus -ve polarity antigenic structure in immune test / VN / CF / HAI secretory antibodies (IgA) - ABC For recovery, D. Serological - nasal interferons IgG antibodies are usually sought - cellular immunity Need 10-14 days to detect < four fold rise in IgG antibody titer F: Paramyxoviridae RNA and Antigenic G: Respirovirus 1, 3 nucleocapsid spikes (Parainfluenza virus) Single stranded and H-an helical nucleocapsid N-an G: Pneumovirus Protein envelope Fuschia (Resp. syncritical virus Virion containing formation of RSV with 3 serotypes) RNA polymerase multinucleated G: Morbillivirus ( -ve polarity) giant cells
G: Orthoreovirus icosahedral capsid Double hemagglutinin without envelope stranded DNA Type specific genome A- Virion has RNA dependant polymerase INFLUENZA Medium sized Segmented Tissue culture Protective viral Droplets spread by cough and A. Specimens Treatment Enveloped Single Chicken antigens: sneezing F: Orthomyxoviridae stranded embryo - haemagglutinin Nasopharyngeal aspirates Severe influenza infection : Negative sense Lab. Animals ( H-an) - Rimantidine G: Influenza Virus RNA genome - nueradiminase B. Rapid Diagnosis - Amantidine Helical (N-an) Have A,B,C, subtype Detection of viral antigen by CF and ELISA Ribavirin (Type A and B) symmetry according to internal Antigenic PCR can also be used Interferon structural antigens changes Ig antiviral Antigenic drift C. Virological Exam - structural Immunoprophylaxis changes in Inoculation into cultural model antigens H and N Indication of viruses depends on sensitive system but main Vaccination due to viral test is HA-test - Live vaccine genome mutation Identification - Killed vaccine formalin killed - Subunit vaccine (have H and N antigen) Antigenic shift D. Serological Exam - Split vaccine ( have H and N antigen -structural chemical treatment to decrease pyrogen) changes in H or Rise in IgG antibody N antigen Chemoprophylaxis Detection by CF, HAI resulting in new subtype Rimantidin (against influenza A but not B)
Epidemiology Pathogenesis Clinical Manifestations
Different degrees of epidemics or global Site of infection is the ciliated columnar Sudden fever, chills, headache, myalgia, pandemics epithelial cells dry cough Usually in young adults, but with higher Early stage : necrosis of nasal and Sore throat, nasal stuffiness mortality in the elderly tracheal ciliated cells Have primary pneumonia Spread occlusively in winter Virus imparts chemotaxis and Have bacterial superinfection phagocytosis by macrophages and (pneumococci, staphylococci aureus) neutrophils Influenza B and C more severe than Secondary -> illness and death Influenza A Influenza B can cause ocular diseases